DRIO

DarioHealth Corp.

$2.39

16.02%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.

Source: Yahoo Finance
AI summary

Price & performance

1M-50.5%
3M-56.8%
YTD-67.6%
1Y-77.1%
52-week range—
Beta0.79
Full chart and returns against a benchmark

Q-Score

32/ 100

Quality against peers; 50 is the peer median.

Growth32
Risk38
Performance30
Valuation45
Profitability39
Leverage35
Sentiment68
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$22.4M-17.3%
Net income-$41.7M
Net margin-186.6%-28.5 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

DRIOIndustryP/E—67.40P/S1.124.25EV/EBITDA—44.97P/B0.436.14PEG—0.25
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report, before the open
EPS estimate$-0.51
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate